Catalyst Capital Advisors LLC Edwards Lifesciences Corp Transaction History

Catalyst Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$46.41 - $56.94 $26,685 - $32,740	-575 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$45.7 - $58.03 $4,570 - $5,803	-100 Reduced 14.81%	575 $100,000
Q2 2018 Aug 07, 2018	SELL	$42.45 - $51.3 $826,713 - $999,067	-19,475 Reduced 96.65%	675 $98,000
Q1 2018 May 18, 2018	SELL	$37.19 - $47.45 $256,610 - $327,405	-6,900 Reduced 25.51%	20,150 $2.81 Million
Q4 2017 Feb 08, 2018	BUY	$33.79 - $39.39 $69,269 - $80,749	2,050 Added 8.2%	27,050 $3.05 Million
Q3 2017 Nov 08, 2017	BUY	$36.29 - $38.83 $907,250 - $970,750	25,000	25,000 $2.73 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.